Data / Form D filings / Crossbow Therapeutics, Inc.
Crossbow Therapeutics, Inc.: Form D filings
Crossbow Therapeutics, Inc., a biotechnology company in Cambridge, MA, filed 2 Form D notices with the SEC between 2023 and 2025. The latest, on September 30, 2025, reports $30.3 million sold of a $80 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1030 Massachusetts Ave, Suite 210, Cambridge, MA, 02138
- Phone
- (860) 501-1600
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1972912
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | New notice | $80,000,000 | $30,250,000 | $49,750,000 | 17 | Sep 17, 2025 | sec.gov |
| Apr 12, 2023 | New notice | $80,000,000 | $37,568,164 | $42,431,836 | 15 | Mar 29, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alexander Nolte | Executive Officer | |
| Alexandra Cantley | Director | |
| Dmitri Wiederschain | Executive Officer | |
| Sakae Asanuma | Director | |
| Charles Baum | Director | |
| Briggs Morrison | Executive Officer, Director, Promoter | |
| Irena Melnikova | Director | |
| Alon Lazarus | Director | |
| Todd Foley | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Sep 29, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Crossbow Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.